Boys Arnold & Co. Inc. bought a new position in shares of Monsanto Company (NYSE:MON) in the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The firm bought 1,707 shares of the basic materials company’s stock, valued at approximately $202,000.
Several other large investors have also added to or reduced their stakes in MON. Acrospire Investment Management LLC bought a new stake in shares of Monsanto during the first quarter worth $113,000. Pinnacle Financial Partners Inc. bought a new stake in shares of Monsanto in the second quarter valued at about $114,000. JNBA Financial Advisors raised its holdings in shares of Monsanto by 3.9% in the first quarter. JNBA Financial Advisors now owns 1,193 shares of the basic materials company’s stock valued at $135,000 after acquiring an additional 45 shares in the last quarter. Armbruster Capital Management Inc. raised its holdings in shares of Monsanto by 12.2% in the second quarter. Armbruster Capital Management Inc. now owns 1,147 shares of the basic materials company’s stock valued at $136,000 after acquiring an additional 125 shares in the last quarter. Finally, Penserra Capital Management LLC raised its holdings in shares of Monsanto by 9.5% in the first quarter. Penserra Capital Management LLC now owns 1,288 shares of the basic materials company’s stock valued at $145,000 after acquiring an additional 112 shares in the last quarter. Institutional investors and hedge funds own 74.79% of the company’s stock.
In other Monsanto news, EVP Steven Mizell sold 11,300 shares of the firm’s stock in a transaction dated Monday, July 3rd. The shares were sold at an average price of $118.57, for a total transaction of $1,339,841.00. Following the completion of the transaction, the executive vice president now owns 55,011 shares in the company, valued at $6,522,654.27. The sale was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, EVP Robert T. Fraley sold 52,410 shares of the firm’s stock in a transaction dated Monday, July 10th. The stock was sold at an average price of $117.95, for a total transaction of $6,181,759.50. The disclosure for this sale can be found here. 0.79% of the stock is owned by company insiders.
Shares of Monsanto Company (NYSE:MON) traded up 0.336% on Friday, hitting $117.995. The stock had a trading volume of 998,254 shares. The firm’s 50-day moving average is $117.23 and its 200-day moving average is $116.41. Monsanto Company has a one year low of $97.35 and a one year high of $118.97. The company has a market cap of $51.84 billion, a price-to-earnings ratio of 25.485 and a beta of 1.07.
Monsanto (NYSE:MON) last released its earnings results on Wednesday, June 28th. The basic materials company reported $1.93 earnings per share for the quarter, topping analysts’ consensus estimates of $1.74 by $0.19. The business had revenue of $4.23 billion for the quarter, compared to the consensus estimate of $4.18 billion. Monsanto had a return on equity of 45.26% and a net margin of 14.11%. The firm’s revenue for the quarter was up 1.0% compared to the same quarter last year. During the same period last year, the business earned $2.17 earnings per share. On average, analysts expect that Monsanto Company will post $4.89 EPS for the current fiscal year.
The firm also recently declared a quarterly dividend, which will be paid on Friday, October 27th. Shareholders of record on Friday, October 6th will be paid a dividend of $0.54 per share. This represents a $2.16 dividend on an annualized basis and a yield of 1.84%. The ex-dividend date of this dividend is Thursday, October 5th. Monsanto’s dividend payout ratio is 46.75%.
A number of brokerages have commented on MON. UBS AG downgraded shares of Monsanto from a “positive” rating to a “neutral” rating in a report on Tuesday, June 27th. Zacks Investment Research upgraded Monsanto from a “hold” rating to a “buy” rating and set a $132.00 price target on the stock in a research note on Thursday. BidaskClub lowered Monsanto from a “hold” rating to a “sell” rating in a research note on Sunday, July 16th. Piper Jaffray Companies set a $128.00 price target on Monsanto and gave the stock a “buy” rating in a research note on Friday, August 11th. Finally, Vetr upgraded Monsanto from a “hold” rating to a “buy” rating and set a $122.35 price target on the stock in a research note on Tuesday, June 27th. One analyst has rated the stock with a sell rating, ten have issued a hold rating and nine have given a buy rating to the stock. The company has an average rating of “Hold” and a consensus target price of $123.49.
Monsanto Company (Monsanto), along with its subsidiaries, is a provider of agricultural products for farmers. The Company provides seeds, biotechnology trait products, herbicides and digital agriculture tools to farmers. The Company operates through two segments: Seeds and Genomics, and Agricultural Productivity.
Receive News & Ratings for Monsanto Company Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Monsanto Company and related companies with our FREE daily email newsletter.